Narayana Hrudayalaya India margins rise to 25.1% in Q4FY26
Narayana Hrudayalaya released the transcript of its Q4FY26 earnings call, detailing operational metrics and strategic guidance. India hospital margins expanded to 25.1% driven by complex procedures in Bangalore. The company plans to double its clinic count, including expansion into Kolkata in FY27. International updates include ongoing cost integration for the UK acquisition and managing losses in the Cayman insurance business.
*this image is generated using AI for illustrative purposes only.
Narayana Hrudayalaya Limited has released the transcript of its earnings call for the quarter and financial year ended March 31, 2026. The call, held on May 26, 2026, featured management discussing financial results, operational efficiencies, and strategic initiatives across its India, Cayman Islands, and UK businesses. The transcript is now available on the company's stakeholder relations website, providing detailed insights into the company's performance and future outlook.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Sridhar S., Group Company Secretary, Legal & Compliance Officer.
Key Operational Updates
During the call, management highlighted significant progress in high-end medical procedures, particularly in the Bangalore cluster. The facility performs approximately 100 robotic cardiac surgeries per month and around 160 percutaneous aortic valve reimplantation procedures. The company emphasized that the complexity of cases delivered in Bangalore has driven financial gains, with the hospital business in India seeing margins expand to 25.1% in Q4FY26 from 21.5% in the same quarter of the previous year.
Strategic Guidance and Expansion
Management addressed questions regarding the company's integrated care model, specifically the role of pharmacies and clinics. Viren Shetty, Vice Chairman, clarified that all pharmacies within hospitals and clinics are part of the listed entity's P&L and serve internal demand rather than operating as a standalone retail vertical. The company plans to expand its clinic footprint, aiming to double the current number of clinics, including expansion into Kolkata in FY27.
Financial Performance and Outlook
The company provided updates on its international acquisitions. For the UK business, acquired in the previous year, management noted that while margins have shown improvement, a few more quarters are needed to fully baseline costs and provide consistent commentary. The GBP 150 million loan taken for the acquisition is being serviced locally in the UK, mitigating currency risk. In the Cayman Islands, the insurance business is experiencing losses due to a faster-than-anticipated ramp-up, with price increases expected to improve the loss ratio over the next three quarters.
Call Details
| Detail | Information |
|---|---|
| Event | Earnings Call Transcript Release |
| Period | Quarter and financial year ended March 31, 2026 |
| Date of Call | May 26, 2026 |
| Availability | Company Website |
The transcript can be accessed via the stakeholder relations section of the Narayana Hrudayalaya website.
Historical Stock Returns for Narayana Hrudayalaya
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.59% | +1.51% | +10.34% | -0.31% | +11.20% | +299.55% |
How will the planned doubling of clinic footprint and expansion into Kolkata impact capital expenditure and operating leverage in FY27?
What specific timeline does management anticipate for the UK business to fully baseline costs and provide consistent margin guidance?
Will the success of high-end procedures in Bangalore drive the rollout of robotic cardiac programs to other clusters within India?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
